Natalia A. Kuzminykh

Natalia A. Kuzminykh

Auto-generated profile, based on publicly available information

Natalia A. Kuzminykh

The Institute of Internal and Preventive Medicine – a branch of a Federal Publicly Funded Institution «Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
YRYu. I. Ragino
Yu. I. Ragino
NKN. A. Kuzminykh
N. A. Kuzminykh
LSL. V. Shcherbakova
L. V. Shcherbakova
DDDiana Denisova
Diana Denisova
VSViktoriya Shramko
Viktoriya Shramko
MVMikhail Voevoda
Mikhail Voevoda
Распространенность ишемической болезни сердца (по эпидемиологическим критериям) и ее ассоциации с липидными и нелипидными факторами риска в популяции 25-45 лет Новосибирска

29 May 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AAAlena Afanaseva
Alena Afanaseva
YPYana Polonskaya
Yana Polonskaya
LSL. V. Shcherbakova
L. V. Shcherbakova
VSViktoriya Shramko
Viktoriya Shramko
NKN. A. Kuzminykh
N. A. Kuzminykh
ЯПЯ. В. Полонская
Я. В. Полонская
Aim.To evaluate the associations of abdominal obesity (AO), adipokines and premature coronary artery disease (CAD) in young people for a deeper understanding of the pathogenesis of atherosclerotic diseases.Material and methods.A total of 1457 people were examined, including 653 (44,8%) men. Mean age was 36,7±6,0 years. Premature CAD was detected in 46 people, while 4 following subgroups were formed (138 people in total): with CAD and AO; with CAD, without AO; control groups by age and sex: without CAD, with AO; without CAD, without AO.Results.Premature CAD in young people is associated with an increase in non-high-density lipoprotein cholesterol (non-HDL-C). Univariate analysis found that the probability of CAD increased by 1% with an increase in adiponectin level, and by 0,2% with an increase of 1 ng/ml in resistin level. Multivariate regression analysis, including sex, age, waist circumference, non-HD-C, adiponectin, and resistin, significant associations were obtained for non-HDL-C and adiponectin. With AO, the CAD probability increased by 0,6% with an increase in plasminogen activator inhibitor-1 level (PAI-1). However, when non-HDL-C was included in the model, significance for this biomarker was not achieved.Conclusion.In young people, CAD is associated with increased levels of non-HDL cholesterol, adiponectin, resistin and PAI-1. Independent associations with premature CAD were obtained only for adiponectin, which makes this marker promising for study in young people.

10 August 2021 in Ateroscleroz
Verified
Journal Article
Open access
PDF file
NKN. A. Kuzminykh
N. A. Kuzminykh
LSL. V. Shcherbakova
L. V. Shcherbakova
VSViktoriya Shramko
Viktoriya Shramko
DDDiana Denisova
Diana Denisova
Yuliya RaginoYuliya Ragino
Yuliya Ragino
Ассоциации ЭКГ феномена TV1>TV6 как электрофизиологического признака метаболических нарушений миокарда с факторами риска ишемической болезни сердца в популяции 25–44 лет

1 January 2021 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
NKN.A. Kuzminykh
N.A. Kuzminykh
LSL.V. Shcherbakova
L.V. Shcherbakova
VSViktoriya Shramko
Viktoriya Shramko
DDDiana Denisova
Diana Denisova
Yuliya RaginoYuliya Ragino
Yuliya Ragino

30 June 2024 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
NKNatalia A. Kuzminykh
Natalia A. Kuzminykh
Yuliya RaginoYuliya Ragino
Yuliya Ragino
Highlights The main ECG parameters associated with cardiovascular mortality in metabolic cardiomyopathy are P-wave changes, QT prolongation, ECG signs of left ventricular hypertrophy, depression and ST segment elevation, T-wave changes. These simple ECG markers are valuable signs of an unfavorable prognosis in patients with myocardial metabolic disorders. AbstractCardiovascular diseases (CVD) are the leading cause of death globally, one of the initial manifestations of these diseases are metabolic changes in the myocardium. Risk stratification in a young population makes would make it possible to timely identify such conditions and prevent their development, as well as their further progression. Electrocardiography is an effective, reliable, accessible and inexpensive method used in clinical practice and research. The aim of this article was to review electrocardiographic (ECG) features associated with manifestations of myocardial metabolic disorders, the mechanisms underlying these associations, and to briefly describe the main research findings in this area and consider the implications for clinical practice. The material and methods were literature sources analyzing metabolic changes in the myocardium and their electrophysiological manifestations, the following databases were used to search for relevant articles: elibrary.ru, pubmed.ncbi.nlm.nih.gov, researchgate.net. The results of the analysis showed that the main changes in ECG parameters associated with cardiovascular mortality in metabolic cardiomyopathy are P-wave changes, QT prolongation, ECG signs of left ventricular hypertrophy, depression and ST segment elevation, T-wave changes. Thus, simple ECGs-markers remain valuable indicators of an adverse prognosis for patients with metabolic disorders of the myocardium.

18 November 2021 in Complex Issues of Cardiovascular Diseases
Verified
Journal Article
Open access
PDF file
NKN. A. Kuzminykh
N. A. Kuzminykh
LSL. V. Shcherbakova
L. V. Shcherbakova
VSViktoriya Shramko
Viktoriya Shramko
DDDiana Denisova
Diana Denisova
Yuliya RaginoYuliya Ragino
Yuliya Ragino
Aim. To study the associations of electrophysiological signs of metabolic disorders with lipid and non-lipid risk factors in the urban 25–44-year-old population.Methods. A population survey (random sample) of Novosibirsk residents aged 25–44 years (656 men, 783 women) was conducted. The concentrations of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol, and triglycerides were determined. Systolic / diastolic blood pressure, body mass index, presence of arterial hypertension, and smoking status were evaluated. The following electrocardiographic markers of metabolic disturbances were analyzed: baseline non-ischemic ST elevation depression >0.5 mm, baseline ST elevation >0.5 mm, and T-wave changes (flattening, amplitude reduction, inversion).Results. ST segment depression was detected in 4.2% of subjects (5.8% women, 2.4% men (p = 0.001)). ST segment elevation was detected in 28.5% of subjects (17.5% women, 41.6% men (p<0.001)). T-wave changes were detected in 18.9% of subjects (14.2% women, 24.5% men (p<0.001)). It was noted that men with elevated LDL-C levels and hypertension were more likely to have ST segment depression (1.4 and 1.9 times, respectively) than men without these abnormalities. In the general population, people with elevated LDL-C levels were 1.2 times more likely to have ST segment depression. Among men with ST segment elevation the concentration of LDL-C in the blood was 1.06 times higher than in men without ST segment elevation. People with a higher body mass index were 1.15 and 1.3 times more likely to have a T-wave change (in the general and female population, respectively). In the general population with T-wave changes, waist circumference and systolic blood pressure level were 1.02 and 1.02 times higher, respectively.Conclusion. ST segment elevation and depression, and T-wave changes are associated with lipid and non-lipid risk factors for ischemic heart disease. The data obtained indicate a potentiating effect of metabolic disorders in the body on the development of risk factors for ischemic heart disease and metabolic cardiomyopathy.